Tag: New York

Measles vaccination coverage has not yet returned to pre-Covid levels globally, leading to a 20% increase in measles cases in 2023 compared to the previous year, as per a recent report from the World...

Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...

The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be no more effective than a placebo in a large clinical...

Michelle Monje-Deisseroth, a medical student about 20 years ago, treated patients with a type of brain tumor called diffuse intrinsic pontine gliomas, or DIPG. These tumors are difficult to treat because they wrap around...

Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...

Good morning and welcome to a new week of work. We hope you had a refreshing weekend because now it's time to get back to the usual routine of online meetings, phone calls, and...

Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....

Generalized Pustular Psoriasis (GPP) is a skin condition that can affect individuals of any age, but it is most commonly seen in middle-aged adults, with a higher prevalence in women. The condition is characterized...

President-elect Trump has chosen Dr. Mehmet Oz, a well-known surgeon and television personality, to lead the Centers for Medicare and Medicaid Services. This agency plays a crucial role in setting policies that affect payments...

Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...

Intellia Therapeutics CEO John Leonard has been facing a familiar situation for the past few years. The company has been sharing positive results from its gene editing trials, only to see its stock prices...

Dear Readers, I have written to you before to talk about the importance of subscribing to STAT for our comprehensive coverage of health and medicine. Today, I feel compelled to reiterate this message as we...